Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists

Details for Australian Patent Application No. 2004240705 (hide)

Owner Merck Frosst Canada & Co.

Inventors Guay, Daniel; Wang, Zhaoyin; Beaulieu, Christian; Li, Lianhai; Sturino, Claudio

Agent Spruson & Ferguson

Pub. Number AU-A-2004240705

PCT Pub. Number WO2004/103970

Priority 60/471,957 20.05.03 US

Filing date 18 May 2004

Wipo publication date 2 December 2004

International Classifications

C07D 209/94 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/88 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/403 - condensed with carbocyclic rings, e.g. carbazole

A61P 011/06 Drugs for disorders of the respiratory system

A61P 011/02 Drugs for disorders of the respiratory system

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/103970 Priority application(s): WO2004/103970

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240707-Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's Disease

2004240704-Hepatitis C inhibitor compounds